Developer docs
API playgroundTry for free, no card

Search company profiles

BebeVida

Full company profile

uuid00266mf

Namestring
BebeVida
Legal namestring
Bebé Vida Ciências para a Vida, S.A.
Websiteurl
bebevida.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

BebéVida — formally Bebé Vida Ciências para a Vida, S.A. — is a Portuguese biotechnology company founded in 2004 and headquartered in Porto, with a secondary office in Lisbon. It operates the country's first and only cryopreservation laboratory dedicated to stem cells derived from umbilical cord blood and umbilical cord tissue, holding dual international accreditations from the AABB (Association for the Advancement of Blood & Biotherapies) and FACT (Foundation for Accreditation of Cellular Therapy) — a status no other laboratory in Portugal or Europe currently matches. The core technology centers on cryogenic long-term storage of hematopoietic and mesenchymal stem cells at extremely low temperatures, supported by advanced laboratory equipment and quality protocols authorized by the Portuguese Ministry of Health.

The company's product portfolio includes the primary cord blood and tissue cryopreservation service (Criopreservação de Células Estaminais), an end-to-end collection kit, the Maternal-Fetal Parallel Bank (Banco Materno-Fetal) storing maternal plasma, peripheral blood, baby plasma and cord fragments, Platelet Gel (Gel Plaquetário) from peripheral blood launched in 2013, and a complementary 4D ultrasound service (ECOmybaby). Samples are stored under contract for up to 25 years, with 100% compatibility for the child and 25% compatibility between siblings cited as functional benefits, alongside claims of potential utility against 80+ treatable diseases.

The business model combines a one-time processing fee (covering the cryopreservation kit, administration, and component validation) with recurring annual storage fees over the 25-year storage period. Distribution is primarily direct-to-consumer via phone, email, and an online service portal, supplemented by healthcare-professional referrals through hospitals and maternity wards, an insurance protocol with ASISA offering cost-free cryopreservation to eligible policyholders, and an institutional partnership with Caixa Geral de Depósitos. The company reaches expecting parents through content marketing, recurring events (Maratona da Maternidade, Simpósio da Grávida), social media (Facebook, Instagram, YouTube), and a long-running celebrity ambassador program. All operations are conducted within Portugal with no disclosed international expansion, and the company remains privately held with no external funding rounds identified.

Short descriptiontext

BebéVida is a Porto-based Portuguese cryopreservation laboratory founded in 2004 that collects, processes, and stores umbilical cord blood and tissue stem cells for expecting families, holding dual AABB and FACT international accreditations unique in Portugal and Europe.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPorto, Portugal
HQ citystring
Porto
HQ countrystring
Portugal
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
stem cell cryopreservation, umbilical cord blood banking, cord tissue preservation, biological sample storage, maternal-fetal biobanking
Industry3 codes
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAGAIAJ
Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats)
SECONDARYHLAFAMAG
Transfusion Medicine & Immunohematology (Blood Bank)
NAICS code2 codes
  • Blood and Organ Banks621991
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Stem Cell Cryopreservation Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Cryopreservation Services
TypeSubscription Recurring
Description

One-time process opening fee includes cryopreservation kit, administrative services, and component validation. Annual storage fee for maintaining samples over 25-year storage period.

bebevida.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

BebéVida operates a cryopreservation laboratory in Portugal that collects, processes, and stores hematopoietic and mesenchymal stem cells harvested from umbilical cord blood and tissue at the time of birth. The company also offers a parallel maternal-fetal bank storing maternal plasma, maternal peripheral blood, baby plasma, and cord fragments, complemented by platelet gel and 4D ultrasound services. Samples are stored in cryopreservation tanks for up to 25 years for potential future therapeutic use.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 60,000+ therapies performed using cryopreserved stem cells
+2 more records
Product overview1 text field

BebéVida operates as a cryopreservation laboratory offering stem cell banking services from umbilical cord blood and tissue. The core service is Criopreservação de Células Estaminais, which includes a collection kit, laboratory processing, cryopreservation, and 25-year storage. The product portfolio is complemented by the Banco Materno-Fetal (Maternal-Fetal Bank), which stores additional biological products including maternal plasma, peripheral blood, baby plasma, and cord fragments. Additional services include ECOmybaby (4D ultrasound) and Gel Plaquetário (platelet gel from peripheral blood). The company operates in partnership with ASISA for cost-free cryopreservation programs.

Product and service5 records
1Criopreservação de Células Estaminais (Stem Cell Cryopreservation)
CategoryCryopreservation Services
Description

Core cryopreservation service for hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from umbilical cord tissue, collected at birth and stored for up to 25 years for potential future therapeutic use in treating 80+ diseases.

2Kit de Criopreservação (Cryopreservation Kit)
CategoryCollection Supplies
Description

Collection kit delivered to expecting families before birth, used by healthcare professionals at the delivery room to collect umbilical cord blood and/or tissue samples and transport them safely to the laboratory for processing and storage.

3Banco Materno-Fetal / Banco Paralelo (Maternal-Fetal Parallel Bank)
CategoryBiological Banking Services
Description

Parallel biological banking service that stores maternal plasma, maternal peripheral blood, baby plasma, and umbilical cord fragments alongside cord blood and tissue, creating a comprehensive maternal-fetal biological bank for potential future therapeutic applications.

4Gel Plaquetário (Platelet Gel from Peripheral Blood)
CategoryTherapeutic Biological Products
Description

Platelet gel obtained from peripheral blood, a biological product for therapeutic applications, launched as an expansion of BebéVida's service portfolio.

5ECOmybaby (4D Ultrasound)
CategoryDiagnostic Imaging Services
Description

4D ultrasound service providing emotional bonding experiences between expecting parents and their babies before birth, offered as a complementary maternity service.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1ASISA
Strategic tierCoreTypeGTM or Marketing Partner
Description

Health insurance protocol offering cost-free cryopreservation services to ASISA policyholders. Enables families with ASISA insurance to preserve their baby's stem cells without costs.

bebevida.com
Strategic tierMinorTypeGTM or Marketing Partner
Description

Institutional partners and customers of Caixa Geral de Depósitos receive special conditions for cryopreservation services.

Strategic tierMinorTypeOthers
Description

Charitable partnership for childhood cancer awareness campaigns. Created solidarity mascots for International Day of Children with Cancer (February 15).

Strategic tierMinorTypeGTM or Marketing Partner
Description

Partnership for sharing customer data with BabyFirst partners for special offers and campaigns related to maternity and infant services.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

Cells4Life is one of the UK's largest private cord blood and tissue banks, offering whole cord blood and cord tissue storage. Regional European peer operating in the same family banking category as BebeVida.

TypeDirect peer
Description

CBR is among the largest private family cord blood banks in the world, providing collection kit, processing, and storage services. A close direct competitor to BebeVida's core offering, though operating primarily in the North American market.

TypeDirect peer
Description

Americord is a US-based private cord blood and tissue bank offering CryoMaxx processing technology and family banking services. Comparable to BebeVida's premium family banking positioning.

TypeDirect peer
Description

Cryo-Cell International is one of the largest and longest-operating private cord blood banks globally, offering umbilical cord blood and tissue cryopreservation services to families. Direct competitor to BebeVida in the family cord blood banking market.

TypeDirect peer
Description

StemCyte operates both public and private cord blood banking programs internationally with AABB and FACT accreditations. Highly comparable to BebeVida given overlapping regulatory accreditations and cord blood banking focus.

TypeRegional player
Description

FamiCord is the largest cord blood bank in Europe by sample volume, operating across multiple EU countries through subsidiaries including Polski Bank Komórek Macierzystych (PBKM). Major European competitor with broader geographic reach than BebeVida.

TypeRegional player
Description

Future Health Biobank is a UK-headquartered private stem cell bank offering cord blood, cord tissue, and dental pulp storage across multiple European markets. Comparable European peer in the family banking category.

TypeDirect peer
Description

ViaCord is a US-based private cord blood and cord tissue bank serving expecting families with collection, processing, and long-term cryopreservation services. Operates in a comparable family-focused D2C banking model to BebeVida.

TypeOthers
Description

CEVEC is a bioprocessing company specializing in cell and gene therapy manufacturing, including cell banking infrastructure. Adjacent rather than directly competing, but provides broader context on the European cell therapy ecosystem in which BebeVida operates.

TypeRegional player
Description

Smart Cells is a UK-based private cord blood bank with international operations, including collection services in multiple countries. Regional European peer in family cord blood banking.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BebeVida

Stem Cell Cryopreservation Servicesbebevida.com

BebéVida is a Porto-based Portuguese cryopreservation laboratory founded in 2004 that collects, processes, and stores umbilical cord blood and tissue stem cells for expecting families, holding dual AABB and FACT international accreditations unique in Portugal and Europe.

What BebeVida does

BebéVida — formally Bebé Vida Ciências para a Vida, S.A. — is a Portuguese biotechnology company founded in 2004 and headquartered in Porto, with a secondary office in Lisbon. It operates the country's first and only cryopreservation laboratory dedicated to stem cells derived from umbilical cord blood and umbilical cord tissue, holding dual international accreditations from the AABB (Association for the Advancement of Blood & Biotherapies) and FACT (Foundation for Accreditation of Cellular Therapy) — a status no other laboratory in Portugal or Europe currently matches. The core technology centers on cryogenic long-term storage of hematopoietic and mesenchymal stem cells at extremely low temperatures, supported by advanced laboratory equipment and quality protocols authorized by the Portuguese Ministry of Health.

The company's product portfolio includes the primary cord blood and tissue cryopreservation service (Criopreservação de Células Estaminais), an end-to-end collection kit, the Maternal-Fetal Parallel Bank (Banco Materno-Fetal) storing maternal plasma, peripheral blood, baby plasma and cord fragments, Platelet Gel (Gel Plaquetário) from peripheral blood launched in 2013, and a complementary 4D ultrasound service (ECOmybaby). Samples are stored under contract for up to 25 years, with 100% compatibility for the child and 25% compatibility between siblings cited as functional benefits, alongside claims of potential utility against 80+ treatable diseases.

The business model combines a one-time processing fee (covering the cryopreservation kit, administration, and component validation) with recurring annual storage fees over the 25-year storage period. Distribution is primarily direct-to-consumer via phone, email, and an online service portal, supplemented by healthcare-professional referrals through hospitals and maternity wards, an insurance protocol with ASISA offering cost-free cryopreservation to eligible policyholders, and an institutional partnership with Caixa Geral de Depósitos. The company reaches expecting parents through content marketing, recurring events (Maratona da Maternidade, Simpósio da Grávida), social media (Facebook, Instagram, YouTube), and a long-running celebrity ambassador program. All operations are conducted within Portugal with no disclosed international expansion, and the company remains privately held with no external funding rounds identified.

BebeVida firmographics

Firmographics
Name
BebeVida
Legal name
Bebé Vida Ciências para a Vida, S.A.
Website
https://bebevida.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
11–50 employees
Short description
BebéVida is a Porto-based Portuguese cryopreservation laboratory founded in 2004 that collects, processes, and stores umbilical cord blood and tissue stem cells for expecting families, holding dual AABB and FACT international accreditations unique in Portugal and Europe.
Ownership category
akta.pro rank

BebeVida industry classification

Industry
Product category
Stem Cell Cryopreservation Services
NAICS
Blood and Organ Banks (621991), Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAGAIAJ
Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats)
SECONDARYHLAFAMAG
Transfusion Medicine & Immunohematology (Blood Bank)

Keywords

  • Stem cell cryopreservation
  • Umbilical cord blood banking
  • Cord tissue preservation
  • Biological sample storage
  • Maternal-fetal biobanking

Where BebeVida is headquartered

Location

Headquarters

HQ city
Porto
HQ country
Portugal
HQ region
Europe

Offices2 records

Markets served

BebeVida business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Cryopreservation Services: One-time process opening fee includes cryopreservation kit, administrative services, and component validation. Annual storage fee for maintaining samples over 25-year storage period.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

BebeVida product offering

Product offering

Core offering

BebéVida operates a cryopreservation laboratory in Portugal that collects, processes, and stores hematopoietic and mesenchymal stem cells harvested from umbilical cord blood and tissue at the time of birth. The company also offers a parallel maternal-fetal bank storing maternal plasma, maternal peripheral blood, baby plasma, and cord fragments, complemented by platelet gel and 4D ultrasound services. Samples are stored in cryopreservation tanks for up to 25 years for potential future therapeutic use.

Product overview

BebéVida operates as a cryopreservation laboratory offering stem cell banking services from umbilical cord blood and tissue. The core service is Criopreservação de Células Estaminais, which includes a collection kit, laboratory processing, cryopreservation, and 25-year storage. The product portfolio is complemented by the Banco Materno-Fetal (Maternal-Fetal Bank), which stores additional biological products including maternal plasma, peripheral blood, baby plasma, and cord fragments. Additional services include ECOmybaby (4D ultrasound) and Gel Plaquetário (platelet gel from peripheral blood). The company operates in partnership with ASISA for cost-free cryopreservation programs.

Differentiator

Problem solved

Functional benefit

Products and services

  • Criopreservação de Células Estaminais (Stem Cell Cryopreservation) Core cryopreservation service for hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from umbilical cord tissue, collected at birth and stored for up to 25 years for potential future therapeutic use in treating 80+ diseases.
  • Kit de Criopreservação (Cryopreservation Kit) Collection kit delivered to expecting families before birth, used by healthcare professionals at the delivery room to collect umbilical cord blood and/or tissue samples and transport them safely to the laboratory for processing and storage.
  • Banco Materno-Fetal / Banco Paralelo (Maternal-Fetal Parallel Bank) Parallel biological banking service that stores maternal plasma, maternal peripheral blood, baby plasma, and umbilical cord fragments alongside cord blood and tissue, creating a comprehensive maternal-fetal biological bank for potential future therapeutic applications.
  • Gel Plaquetário (Platelet Gel from Peripheral Blood) Platelet gel obtained from peripheral blood, a biological product for therapeutic applications, launched as an expansion of BebéVida's service portfolio.
  • ECOmybaby (4D Ultrasound) 4D ultrasound service providing emotional bonding experiences between expecting parents and their babies before birth, offered as a complementary maternity service.

Quantifiable outcome

  • 60,000+ therapies performed using cryopreserved stem cells
  • +2 more outcomes

Companies that use BebeVida

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

BebeVida technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

BebeVida partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • ASISAcoreGTM or Marketing PartnerHealth insurance protocol offering cost-free cryopreservation services to ASISA policyholders. Enables families with ASISA insurance to preserve their baby's stem cells without costs.
  • Caixa Geral de Depósitos (CGD)minorGTM or Marketing PartnerInstitutional partners and customers of Caixa Geral de Depósitos receive special conditions for cryopreservation services.
  • Make-A-Wish PortugalminorOthersCharitable partnership for childhood cancer awareness campaigns. Created solidarity mascots for International Day of Children with Cancer (February 15).
  • BabyFirstminorGTM or Marketing PartnerPartnership for sharing customer data with BabyFirst partners for special offers and campaigns related to maternity and infant services.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

BebeVida competitors and assessment

Company assessment

Regional players

  • Cells4Life: Cells4Life is one of the UK's largest private cord blood and tissue banks, offering whole cord blood and cord tissue storage. Regional European peer operating in the same family banking category as BebeVida.
  • FamiCord: FamiCord is the largest cord blood bank in Europe by sample volume, operating across multiple EU countries through subsidiaries including Polski Bank Komórek Macierzystych (PBKM). Major European competitor with broader geographic reach than BebeVida.
  • Future Health Biobank: Future Health Biobank is a UK-headquartered private stem cell bank offering cord blood, cord tissue, and dental pulp storage across multiple European markets. Comparable European peer in the family banking category.
  • Smart Cells International: Smart Cells is a UK-based private cord blood bank with international operations, including collection services in multiple countries. Regional European peer in family cord blood banking.

Direct peers

  • Cord Blood Registry (CBR): CBR is among the largest private family cord blood banks in the world, providing collection kit, processing, and storage services. A close direct competitor to BebeVida's core offering, though operating primarily in the North American market.
  • Americord Registry: Americord is a US-based private cord blood and tissue bank offering CryoMaxx processing technology and family banking services. Comparable to BebeVida's premium family banking positioning.
  • Cryo-Cell International: Cryo-Cell International is one of the largest and longest-operating private cord blood banks globally, offering umbilical cord blood and tissue cryopreservation services to families. Direct competitor to BebeVida in the family cord blood banking market.
  • StemCyte: StemCyte operates both public and private cord blood banking programs internationally with AABB and FACT accreditations. Highly comparable to BebeVida given overlapping regulatory accreditations and cord blood banking focus.
  • ViaCord: ViaCord is a US-based private cord blood and cord tissue bank serving expecting families with collection, processing, and long-term cryopreservation services. Operates in a comparable family-focused D2C banking model to BebeVida.

Others

  • CEVEC Pharmaceuticals: CEVEC is a bioprocessing company specializing in cell and gene therapy manufacturing, including cell banking infrastructure. Adjacent rather than directly competing, but provides broader context on the European cell therapy ecosystem in which BebeVida operates.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

BebeVida social profiles

Digital presence

BebeVida compliance and trust

Trust signal

Compliance3 records

BebeVida financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BebeVida leadership team

Management profile

Number of profiles

Profiles2 records

BebeVida funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BebeVida M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BebeVida

What does BebeVida do?

BebéVida operates a cryopreservation laboratory in Portugal that collects, processes, and stores hematopoietic and mesenchymal stem cells harvested from umbilical cord blood and tissue at the time of birth. The company also offers a parallel maternal-fetal bank storing maternal plasma, maternal peripheral blood, baby plasma, and cord fragments, complemented by platelet gel and 4D ultrasound services. Samples are stored in cryopreservation tanks for up to 25 years for potential future therapeutic use.

Is BebeVida a public or private company?

BebeVida is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was BebeVida founded?

BebeVida was founded in 2004. It employs 11 to 50 people.

Where is BebeVida based?

BebeVida is headquartered in Porto, Portugal, in the Europe region.

How does BebeVida make money?

One revenue line is on record: cryopreservation Services.

Who are BebeVida's main competitors?

Regional players on record are Cells4Life, FamiCord, Future Health Biobank and Smart Cells International. Direct peers are Cord Blood Registry (CBR), Americord Registry, Cryo-Cell International, StemCyte and ViaCord. CEVEC Pharmaceuticals is listed as an others.

Does BebeVida have an API?

No public API is recorded for BebeVida.

What industry is BebeVida in?

BebeVida's product category is Stem Cell Cryopreservation Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAGAIAJ, Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats). Its NAICS code is 621991 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals